BCTXZ NASDAQ
BriaCell Therapeutics Corp. Warrant
1W: +86.7%
1M: +55.1%
3M: +222.2%
YTD: +18.4%
1Y: +39.8%
$0.30
+0.14 (+83.95%)
Weekly Expected Move ±49.4%
$0
$0
$0
$0
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Balance Sheet Trends
Total Assets
$22M
+268.7% ▲
5Y CAGR: +110.6%
Total Liabilities
$4M
-49.6% ▼
5Y CAGR: +0.9%
Shareholders Equity
$25M
+1137.7% ▲
Cash & Investments
$18M
+1972.4% ▲
5Y CAGR: +284.5%
Total Debt
$0
+0.0% ▲
Net Debt
-$10M
-1117.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $57M | $41M | $21M | $862K | $10M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $7M |
| Cash & ST Investments | $57M | $41M | $21M | $862K | $18M |
| Net Receivables | $13K | $24K | $718K | $1M | $781K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | -$788K |
| Total Current Assets | $58M | $42M | $27M | $4M | $20M |
| Property, Plant & Equip. | $0 | $0 | $0 | $388K | $297K |
| Goodwill & Intangibles | $246K | $230K | $215K | $200K | $185K |
| Long-Term Investments | $2 | $2 | $2 | $418K | $725K |
| Other Non-Current Assets | $0 | $0 | $0 | $1M | $517K |
| Total Non-Current Assets | $246K | $230K | $215K | $2M | $2M |
| Total Assets | $58M | $43M | $27M | $6M | $22M |
| — Liabilities — | |||||
| Accounts Payable | $214K | $463K | $1M | $7M | $5M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | -$562K |
| Total Current Liabilities | $557K | $941K | $2M | $7M | $4M |
| Long-Term Debt | $26K | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $30M | $31M | $29M | $1M | $338K |
| Total Non-Current Liabilities | $30M | $31M | $29M | $1M | $338K |
| Total Liabilities | $30M | $32M | $31M | $9M | $4M |
| — Equity — | |||||
| Common Stock | $55M | $66M | $70M | $72M | $141M |
| Retained Earnings | -$29M | -$60M | -$81M | -$85M | -$155M |
| Accumulated OCI | -$139K | -$139K | -$139K | -$139K | $39M |
| Total Stockholders Equity | $28M | $10M | -$4M | -$2M | $25M |
| Total Liabilities & Equity | $58M | $43M | $27M | $6M | $30M |
| — Key Metrics — | |||||
| Total Debt | $26K | $0 | $0 | $0 | $0 |
| Net Debt | -$57M | -$41M | -$21M | -$862K | -$10M |
| Total Investments | $2 | $2 | $2 | $418K | $11M |